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Abstract
The worldwide rise in the rates of antibiotic resistance of bacteria underlines the need for alternative antibacterial agents. A
promising approach to kill antibiotic-resistant bacteria uses light in combination with a photosensitizer to induce a
phototoxic reaction. Concentrations of 1, 10 and 100mM of tetrahydroporphyrin-tetratosylat (THPTS) and different
incubation times (30, 90 and 180min) were used to measure photodynamic efficiency against two Gram-positive strains of
S.aureus (MSSA and MRSA), and two Gram-negative strains of E.coli and P.aeruginosa. We found that phototoxicity of the
drug is independent of the antibiotic resistance pattern when incubated in PBS for the investigated strains. Also, an
incubation with 100mM THPTS followed by illumination, yielded a 6lg ($99.999%) decrease in the viable numbers of all
bacteria strains tested, indicating that the THPTS drug has a high degree of photodynamic inactivation. We then modulated
incubation time, photosensitizer concentration and monitored the effect of serum on the THPTS activity. In doing so, we
established the conditions to obtain the strongest bactericidal effect. Our results suggest that this new and highly pure
synthetic compound should improve the efficiency of photodynamic therapy against multiresistant bacteria and has a
significant potential for clinical applications in the treatment of nosocomial infections.
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Introduction
For the past 60 years, antimicrobial chemotherapy has been the
mainstay of medical intervention against infectious diseases caused
by bacterial pathogens. The continuous decline of therapeutic
effectiveness, as a result of extensive use of antibiotics, has long
been predicted [1] and many surveillance efforts over the last
decade have drawn attention to this phenomenon that now
imposes a large burden on health care facilities [2–5].
Since its first appearance in 1960 [6], methicillin resistant
Staphylococcus aureus (MRSA) has become widespread in hospitals
and intensive care units (ICUs) [7], and now accounts for .60% of
S.aureus isolates in US hospital and ICUs [8]. MRSA infections kill
,19,000 hospitalized American patients annually; equivalent to
the combined number of deaths due to AIDS, tuberculosis, and
viral hepatitis [9]. Appearance of new resistance against
vancomycin further aggravate the problem [10,11]. Last but not
least, the increase of Gram-negative pathogens, such as Escherichia
coli (E. coli) and Pseudomonas aeruginosa (P .aeruginosa), with resistance
to all antimicrobial drugs [12,13] has also stimulated an extensive
search for alternative antimicrobial treatment, especially for
localized infections of the skin and oral cavity.
Antimicrobial photodynamic therapy (PDT) was described
more than one hundred years ago by O. Raab and H. von
Tappeiner. It was completely neglected during the golden age of
antibiotic but it is slowly moving out of limbo to offer new
therapeutic opportunities against multiresisitant bacteria [14–16].
Photodynamic inactivation of microorganisms is based on the
properties of dyes, known as photosensitizers, to be preferentially
localized in the bacteria and not in the surrounding tissue. They
are subsequently activated by low doses of visible light of an
appropriate wavelength, generating free radicals or singlet oxygen
that are toxic to target microorganisms [17,18]. Unlike antibiotics,
repeated photosensitizations of bacteria do not induce the selection
PLoS ONE | www.plosone.org 1 July 2010 | Volume 5 | Issue 7 | e11674of resistant strains as singlet oxygen and free radicals interact with
several cell structures and different metabolic pathways in
microbial cells [19].
In the past ten years, the use of Photodynamic treatment against
MRSA has dramatically increased [20–23]. The limitation of this
technique is linked to photosensitizer properties, including the
amount of energy needed to activate the photosensitizer [24,25],
low penetration depth of laser light due to its activating wavelength
[24–26], the charge and purity of the molecule [25–29], specificity
of the photosensitizer for bacteria [30] and the uptake kinetic of
the compound in microorganisms [31]. Therefore, the positively
charged and water-soluble tetrahydroporphyrin dyes have consid-
erable advantages in comparison to other photosensitizers. They
have strong absorption bands in the infrared region and show
much higher uptake in negatively charged mitochondria mem-
brane, which are key regulators of apoptosis by activating the
caspase cascade [32,33].
We previously demonstrated that the tetracationic photosensi-
tizer tetrahydroporphyrin-tetratosylat (THPTS) has a stronger
bactericidal effect on Gram-positive bacteria, in both methicillin
sensitive S. aureus (MSSA) and MRSA, compared to Photolon, a
dianionic chlorine e6 sodium salt drug that has been approved for
photodynamic therapy. We also demonstrated its efficiency against
Gram-negative bacteria (S.aeruginosa and E.coli) while anionic
Photolon was inefficient [34]. In the present study we further
studied the bactericidal efficiency of THPTS on Gram-positive
(MSSA and MRSA) and Gram-negative (E.coli and P.aeruginosa)
bacteria. We determined the optimal incubation times for all
bacterial strains tested and demonstrated that THPTS can
mediate antimicrobial effect of PDT at lower concentration than
previously shown. In addition, for MRSA/MSSA and E.coli, the
bactericidal effect of THPTS was also observed in presence of
serum protein, thus matching more closely the condition of patient
treatment.
Altogether our results suggest that this new and highly pure
synthetic compound should improve the efficiency of PDT against
multiresistant bacteria with a significant potential for clinical
applications in the treatment of nosocomial infections.
Results
Viability of Gram-positive bacteria
MSSA were stained using Syto9 to stain the nuclei and
propidium iodide to detect damaged DNA, causing healthy cell to
be stained in green whereas dying bacteria appear yellow (Fig. 1).
In the control situation (Fig 1 A and magnification in B), when
incubated with THPTS but without being exposed to proper
excitation wavelenght for the photosensitizer, bacteria appeared
labelled in green only, thus demonstrating that THPTS has no
toxicity per se. Few bacteria appeared labelled in yellow (arrows)
and account for the normal rate of dying cells in the suspension.
After incubation with THPTS and excitation, all bacteria were
labelled with propidium iodide and also appeared then in yellow
(Fig 1 C and magnification in D). Therefore, damages induced by
THPTS were due to the photodynamic reaction and not to an
intrinsinc toxicity of THPTS. Before examination, bacteria were
kept in the dark for only 15 min following laser excitation;
therefore, generation of free radicals and ROS took place rapidly
after illumination at proper wavelenght.
Photoinactivation of methicillin-sensitive S.aureus (strain:
DSM 1104)
Without photosensitizer treatment, all bacterial samples exhib-
ited normal growth, demonstrating that the maximal irradiation
dose of 100J/cm
2 alone had no antibacterial effects. Also, without
any irradiation, incubation of bacterial samples for 30; 90 and
180min with different concentrations (1, 10 and 100mM) of
THPTS did not induce any killing effect, thus confirming the
Figure 1. Viability of Gram-positive bacteria using a live/dead assay. Cells were incubate for 90min with THPTS and either kept in the dark
(A, B) or irradiated (C, D) at 760nm. Healthy bacteria were seen in green whereas dying bacteria were also stained with propidium iodie and appeared
therefore in yellow. Dying bacteria could be observed in control panels (arrows in B) but no healthy bacteria were seen in irradiated panel (C and D).
Scale bar 40mm in A and C, 10mm in B and D.
doi:10.1371/journal.pone.0011674.g001
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effect of nearly 0.5log10 (colony-forming unit/ml, CFU/mL) was
measured after irradiation following all incubation times of
bacteria with THPTS in PBS at a concentration of 1mM (Fig. 2).
At this concentration, THPTS effect cannot be exacerbated by
increasing the incubation time. An irradiation of MSSA bacteria,
incubated with THPTS at concentrations of 10 or 100mM in PBS
for 30, 90 or 180 min shows significant (P,0.005) antibacterial
activity of more than 6log10 (CFU/mL) for all the incubation time
tested.
In order to match closer the condition of patient treatment we
then analyzed the effect of human serum (HS) addition (10% in
PBS). In this condition, 30min of incubation using 10 and 100mM
THPTS caused only a moderate decrease of about 2log10 (CFU/
mL) after illumination. It is clear that PDT efficiency can be
dramatically perturbed by the addition of sera. However,
increasing the incubation times to 90 or even 180 minutes allowed
us to overcome the consequence of serum addition and to obtain
again a total absence of bacterial colony in PBS+10%HS using 10
and 100mM of THPTS. In this bacterial strain and in the presence
of serum, increasing the incubation time is sufficient to recover the
complete bactericidal effect of THPTS at 10 and 100mM . Even in
presence of higher human serum concentrations, the photobacter-
icidal effect remained complete with 25% HS using 10 and 100mM
THPTS and above 2log10 for the highest concentration of THPTS
in the presence of 50 and 100% HS (CFU/mL, see supplemental
data, Fig. S1).
Phototoxicity against methicillin-resistant S.aureus
(strain: DSM 11729)
In order to investigate whether the observed growth reduction
of MSSA was independent of the antibiotic resistance pattern, a
MRSA strain was photosensitized under identical conditions to
those used for the MSSA strain. Without being photosensitized all
MRSA samples exhibited normal growth with or without
illumination, demonstrating that the maximal irradiation dose of
100J/cm
2 alone had no antibacterial effects. At the concentration
of 1mM THPTS no photokilling effect was observed for any
period of incubation in PBS as well as in PBS+10% HS. However
for higher THPTS concentrations, MRSA strain shows similar
decreases as MSSA in CFU/ml after incubation and irradiation
(Fig. 2). Irradiation of the MRSA in the presence of 10 and
100mM of THPTS in PBS resulted in a complete absence of CFU
per millilitre (Fig. 3). The total photokilling of the MRSA of more
than 6log10 (CFU/mL) was reached with 30 and 90min
incubations with 10mM and 100mM of THPTS in PBS and with
100mM THPTS in PBS+10% HS. Using 10mM of photosensitizer
in 10% HS the photobactericidal effect decreased but still
remained at 3log10 (CFU/mL). Here we observed that incubation
time has to be limited to 90 min for optimal effect of THPTS and
that serum does not dramatically influence the efficiency of the
photosensitizer when used at 100mM. Using an incubation time of
90min in PBS as well as in PBS+10% HS, a photokilling efficacy
of more than 6log10 (CFU/mL) was always obtained with 100mM
THPTS. A further increasing of incubation time to 3 hours
induced a decrease in the killing rate of these bacteria, both in
PBS and in presence of serum, a phenomena probably linked to
the pharmacokinetic of the compound in this specific bacterial
strain.
Viability of Gram-negative bacteria
E.coli were stained using Syto9 to stain the nuclei and propidium
iodide to detect damaged DNA, causing healthy cell to be stained
in green whereas dying bacteria appear yellow (Fig. 4). In the
control situation, (Fig 4A and magnification in 4B) when incubated
with THPTS but without being exposed to proper excitation
wavelength for the photosensitizer, only few E.coli were seen
labelled in yellow (arrows in Fig. 4A and B). This accounts for the
normal rate of dying cells in the suspension. After incubation with
THPTS and excitation, all bacteria were labelled with propidium
iodide and then also appeared in yellow (Fig 4C and magnification
in 4D). Therefore, damages induced in E.coli by THPTS were due
to the photodynamic reaction and not to an intrinsic toxicity of
THPTS. Before examination, bacteria were kept in the dark for
Figure 2. Photoinactivation of MSSA by THPTS. Photoinactivation of S.aureus (MSSA strain: DSM1104) by THPTS after incubation times of 30, 90
or 180min in PBS (A) or in PBS+10% HS (human serum, B). Viability of MSSA was determined by a CFU assay. Even in presence of serum, 10mMo f
THPTS for 90min had a dramatic bactericidal effect leading to the total absence of colony. Each point is the mean 6 standard deviation of three
experiments (P,0.005). CD: control in the dark, bacteria were maintained in the dark after incubation with THPTS. CL: control with light, no THPTS
incubation before laser treatment. PI: photoinactivation using THPTS at indicated concentrations before laser treatment.
doi:10.1371/journal.pone.0011674.g002
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radicals and ROS took place rapidly after illumination at 760 nm.
Phototoxicity against E.coli (strain: DSM8698)
The incubation of E.coli in the dark with THPTS showed no
decrease in the numbers of CFU per millilitre. Irradiation of the
Gram-negative bacterium E.coli after incubation with THPTS at
concentrations identical to those in the experiments mentioned
above revealed only a small decrease in the log10 (CFU/mL)
numbers compared with staphylococcal strains (Fig. 2 to 3). When
incubated for 30min with THPTS in PBS+10% HS, little or none
photobactericidal effect was observed at all mentioned concentra-
tions (Fig. 5). Irradiation of E.coli incubated for 90min with the
concentration of 10mM of THPTS in PBS and in PBS+10% HS
resulted in a moderate decrease in the numbers of CFU per
millilitre of around 1 to 2log10 (CFU/mL). A longer incubation
time of 180min in PBS, using 10mM of THPTS, showed a
significant increase in the killing rate of E.coli in comparison to the
Figure 3. Photoinactivation of MRSA by THPTS. Photoinactivation of S.aureus (MRSA strain: DSM11729) by THPTS after incubation times of 30,
90 and 180min in PBS (A) and in PBS+10% HS (B). Viability of MRSA was determined by a CFU assay. 10mM of THPTS for 30min were sufficient to
obtain a total absence of colony. However this concentration had to be increased to 100mM in presence of serum. Each bar is the mean 6 standard
deviation of three experiments (P,0.005). CD: control in the dark, CL: control with light, PI: photoinactivation.
doi:10.1371/journal.pone.0011674.g003
Figure 4. Viability of Gram-negative bacteria using live/dead assay. Cells were incubate with THPTS for 90min and either kept in the dark (A,
B) or irradiated (C, D) at 760nm. Healthy bacteria were seen in green whereas dying bacteria were also stained with propidium iodide and appeared
therefore in yellow. Dying bacteria could be observed in controls (arrows in A and B) but no healthy bacteria were seen in irradiated samples (C and
D). Scale bar 40mm in A and C, 10mm in B and D.
doi:10.1371/journal.pone.0011674.g004
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presence of human serum. A moderate photobactericidal effect of
around 3log10 (CFU/mL) was measured after incubation with
100mM of THPTS for 30min in PBS. Nevertheless, the incubation
in PBS at the same THPTS concentration of 100mM induced a
total killing effect of more than 6log10 (CFU/mL) when incubation
time was extend to 90 and 180min. Notably, this bactericidal effect
using 100mM of THPTS was diminished in the presence of human
serum to but not negated.
Phototoxicity against P.aeruginosa (strain: DSM1117)
In the dark, the incubation of P.aeruginosa with THPTS at the
highest tested concentration of 100mM showed no decrease in the
numbers of CFU per millilitre, after 30, 90 and 180min incubation
times in PBS and PBS+10% HS (Fig. 6 A and B). Also, no
photobactericidal effect was observed after the incubation of
P.aeruginosa with THPTS at a concentration of 1mM for 30min in
PBS and for incubations with THPTS at all concentrations and
incubation times in PBS+10% HS. A moderate photobactericidal
Figure 5. Photoinactivation of E. Coli by THPTS. Photoinactivation of E. coli (DSM8698) by THPTS photosensitizer (PS) after incubation times of
30; 90 and 180min in PBS (A) or in PBS+10% HS (B). Viability of bacterial cells was determined by a CFU assay. 100mM of THPTS for 90min, or 10mM for
180min were sufficient to obtain an efficient bactericidal effect. However, serum addition reduced the efficiency of the treatment without abolishing
it when THPTS was incubated for 90min. Each bar is the mean 6 standard deviation of three experiments (P,0.005). CD: control in the dark, CL:
control with light, PI: photoinactivation.
doi:10.1371/journal.pone.0011674.g005
Figure 6. Photoinactivation of P.aeruginosa by THPTS. Photoinactivation of P.aeruginosa (DSM1117) by THPTS photosensitizer (PS) after
incubation times of 30, 90 and 180min in PBS (A) and PBS+10% HS (B). 100mM of THPTS for 30min or 10mM of THPTS for 90min were sufficient to
obtain a total bactericidal effect leading to the complete absence of colony. Serum addition completely abolished the bactericidal effect of THPTS for
this bacterial strain. Viability of bacterial cells was determined by a CFU assay. Each bar is the mean 6 standard deviation of three experiments
(P,0.005). CD: control in the dark, CL: control with light, PI: photoinactivation.
doi:10.1371/journal.pone.0011674.g006
THPTS as Antimicrobial Agent
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incubation with a dose of 10mM of THPTS for 30min in PBS.
The photobactericidal effect was increased by extending the
incubation period to 90min. A total killing of P.aeruginosa of more
than 6log10 (CFU/mL) was measured after incubation with
100mM THPTS for 30, 90 and 180min incubation times in PBS.
Discussion
Bactericidal properties of THPTS
We demonstrated that the PDT inactivation of methicillin-
sensitive and methicillin-resistant strains of S.aureus with THPTS
showedaclearTHPTSdose-dependentviabilitylossafterirradiation
even after incubation in PBS+10% HS (Figs. 1 and 2). It should be
noted that in the presence of different concentrations of human
serum, the growth delay of Gram-positive MRSA bacteria was
nearly a linear function of its concentration.
Different results were found for Gram-negative bacteria. We
observed a high rate of photoinactivation in E.coli that was
preincubated for 90 or 180min with THPTS at 10 or 100mMi n
PBS. A moderate photoinactivation of 2.5 and 3log10 (CFU/mL)
was observed for PBS+10% HS after 90min incubation of the
bacteria with THPTS at concentrations of 10 and 100mM,
respectively. A high photoinactivation of more than 6lg (CFU/mL)
of P.aeruginosa cells was measured only after a preincubation in
PBS, at 10 and 100mM of THPTS. In contrast, the photosensi-
tizing activity of THPTS towards P.aeruginosa was definitely
blocked in serum.
The ability of THPTS to photoinactivate MSSA, MRSA and
Gram-negative E.coli bacteria, even in the presence of blood
proteins and without any additives which increase membrane
permeability, represents an original finding. In a recent paper
Maisch and collaborator described the effects of novels XF
porphyrin derivates, that kills MRSA at the same (10mM)
concentration as THPTS, but unfortunately the author did not
test the influence of serum on the photokilling of Gram-negative
bacteria using their photosensitizer. More recently they used their
compound in an ex-vivo model, confirming the bactericidal effect of
XF porphyrins [34]. The activation range between 380 to 480nm
allowed only a limited penetration (,1mm), thus compatible only
with very superficial infection treatment, rarely seen in case of
nosocomial infection following surgery. Even if it needed to be use
in the 10-100mM range, our new THPTS compound can still
mediate an efficient bactericidal function in presence of large
amounts of serum; a model much closer to the in vivo reality of skin
infection. In addition, our compound might be used in a
therapeutic alternative against P aeruginosa infection, 10mMo f
THPTS incubated for three hours is sufficient to get rid of all
bacterial colonies. Compared to other porphyrin derivates [35]
THPTS exhibit higher efficiency against this bacterial strain.
THPTS could therefore be use to treat with PDT two major
bacterial strain (S.aureaus and P.aeruginosa) found in multiresistant
bacterial infection of skin, lung and blood [36–39].
Our results have clearly demonstrated that meso-substituted
tetracationic THPTS is an efficient photosensitizer for killing
Gram-positive S.aureus (MSSA and MRSA) and Gram-negative
bacteria E.coli and P.aeruginosa with infrared light illumination at
760nm. The near infrared wavelength activation leads to deeper
penetration of the laser beam, allowing it to stimulate our
photosensitizer in thicker tissues (up to 10mm). This is of great
interest for the treatment of resistant bacterial infection following
surgical intervention. Previous publications described meso-
substituted cationic porphyrin that were stimulated in the visible
wavelength [25–29,34], leading to a limited penetration (,1mm)
depth and much lower efficiency of the PDT. Therefore, even if
THPTS is acting at higher concentration than these porphyrins, it
appears much more adapted to clinical applications in the
treatment of wound infection.
Mechanism of action and serum influence
Present results together with previously published studies [25–
29] indicate that positively charged porphyrins are interesting
sensitizers for photoinactivation of both Gram-positive and Gram-
negative bacteria. The selective mechanism of entry of cationic
photosensitizers in bacteria is still poorly understood, but positively
charged photosensitizers seem to move across the outer membrane
via a self-promoted uptake pathway, in a mechanism involving
interaction between divalent cations of the compound with
adjacent bacterial lipopolysaccharide [24]. THPTS may therefore
cross the outer membrane via such a pathway.
A similar mechanism of entry has also been described for
cationic antimicrobial peptide in P.aeruginosa [40]. Serum proteins
might therefore affect THPTS effectiveness by modifying the
lipopolysaccharidic environment present on the bacterial mem-
brane (glycosylation status, charge), and/or bacteria permeability,
thus inducing change in the affinity with cationic THPTS. This
hypothesis is consistent with the fact that serum had a more drastic
effect in Gram-negative bacteria, which possess a more complex
membrane structure than Gram-positive bacteria, with a simpli-
fied membrane. In those bacteria, we established that the effect of
serum can be overcome by modulating either THPTS concen-
tration or incubation time (Fig. 2B and 3B).
Conclusion
The worldwide increase in antibiotic resistance among different
classes of Gram-positive and Gram-negative bacteria has led to a
search for alternative antimicrobial therapies, like antimicrobial
PDT. At this time, there is no routine application of antimicrobial
PDT in the treatment of localized infections. Next step will be to
test THPTS effectiveness in vivo, using animal model of bacterial
infection. Other groups have developed such model for PDT
applications. Hamblin et al., (2003) were able to obtain a high
survival rate of 90% in mice infected with P. aeruginosa by using
poly-L-lysine (pL)-chlorin e6, whereas all mouse from the
untreated control group died rapidly [41]. Zolfaghari et al.,
(2009) observed a strong reduction of viable S. aureus in their
mouse model using methylene blue as a photosensitizer [42].
However, in both studies, photosensitizers did not lead to a
complete photokilling of bacteria in vivo compared to in vitro
results. Efficiency of above photosensitizers was reduce in vivo due
to their inherent limitations: charge, amount of energy needed,
excitation wavelength and light penetration, low specificity of the
photosensitizer for bacteria vs host cells, effect of serum.
Therefore, in vitro results presented here are now calling for
further experiments in vivo that may confirm that THPTS can
meet all requirements in order to use PDT as an alternative option
to antibiotic treatments in clinical practice.
Materials and Methods
Bacteria strains
The organisms used in our studies were three typical members
of the microflora in wounds: The Gram-positive bacterium
Staphylococcus.aureus and the Gram-negative bacteria Escherichia.coli
and Pseudomonas aeruginosa. We used the following strains: S.aureus
DSM1104 (ATCC 25923), the MRSA strain S.aureus DSM11729
(ATCC 33592), E.coli DSM 8698 and P.aeruginosa DSM1117 (ATCC
27853).
THPTS as Antimicrobial Agent
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Tryptic Soy Broth (Merck KGaA Darmstadt, Germany). Cells
were harvested by centrifugation and suspended in sterile
phosphate-buffered saline or sterile PBS supplemented with 10%
sterile human serum (HS). The final OD (optical density) of the
bacterial suspensions at 600nm, 1cm was 0.015 in all cases. The
bacterial suspensions were placed into sterile black well plates with
clear bottoms (Costar 3603, Corning Inc., USA).
Photosensitizer
The novel photosensitizer tetrahydroporphyrin tetratosylat
(THPTS), C72H70N8O12S4, MW 1367.66 was kindly donated by
TetraPDT Inc., D-04519 Rackwitz, Germany. THPTS is a highly
pure (.99,9% HPLC), water soluble, chemical stable, positively
charged compound absorbing with an extinction coefficient of
e=105,000 M
21cm
21 at 760,5nm in water. Photosensitizer stock
solution (2mM) was diluted in H2O and kept in the dark at 4uC. It
was further diluted in PBS (pH 7.4) with RPMI 1640 medium
without phenol red and supplemented with 10% FCS.
Photodynamic inactivation of bacteria suspensions
Suspensions of bacteria were exposed to light from a diode laser
with a wavelength of 76163nm (Ceralas D, Ceramoptec GmbH,
Bonn, Germany) after incubation with the photosensitizer THPTS
for 30, 90 and 180min in the dark at room temperature. The
individual wells of the plate were illuminated via an optical fiber
from the bottom of the plate. The fluence rate for this setting was
about 1W/cm
2 (measured with Optometer P-9710, Gigahertz-
Optik GmbH, Puchheim, Germany). For the used illumination
time (100sec) the resulting total light dose was about 100J/cm
2.
The control samples for dark toxicity were only exposed to the
photosensitizer (final concentration of 100mM) without any
illumination. After illumination the samples were removed from
the wells of the plate, diluted with Tryptic Soy Broth and plated by
using spiral plater Eddy Jet (iul Instruments, Barcelona, Spain) on
Tryptic Soy agar plates. The numbers of colony-forming units
(CFU/mL) were counted after adequate incubation using colony
counter Countermat Flash (iul Instruments, Barcelona, Spain).
Data analysis and statistics
Each experiment was performed at least in triplicate. All
primary data is presented as means with standard deviations of the
mean. Differences were tested for statistical significance by
Student’s t test. Probability values less than 5% were considered
significant.
Viability of bacteria
THPTS was added at final concentration of 250mMt oa
bacterial suspension of S.aureus DSM1104 and E.coli DSM8698
(OD=1.5; 600nm; 1cm for both strains. After an incubation time
of 90min the suspensions were illuminated with laser light (761nm,
150J/cm
2). Right after illumination 50ml of the bacterial
suspension was mixed with 1ml of LIVE/DEAD BacLight solution
(invitrogen, Cat. No. L7012) consisting of a 1:1-mix of Syto9 and
propidium iodide. A live dead assay was then incubated for 15min
in the dark before microscopic procedure using Zeiss ‘‘Axiovert S
100’’ and filter set #09 (Carl Zeiss AG, Jena, Germany).
Micrographs were taken using a ‘‘SPOT slider - RT Realtime’’
camera system in combination with ‘‘SPOT Advanced’’ software
(Visitron Systems GmbH, Puchheim, Germany). Living bacteria
were labelled in green using Syto9 nuclear stain, whereas damaged
bacteria were labelled yellow as they were also stained in red with
propidium iodide. A control was performed by omitting the
760nm illumination in order to test the THPTS toxicity.
Supporting Information
Figure S1 Effect of high serum concentrations. Photoinactiva-
tion of S.aureus (MSSA strain: DSM1104) by THPTS after an
incubation time of 90min in solutions containing 0 to 100% HS
(human serum). Viability of MSSA was determined by a CFU
assay. Even in presence of 25% serum, 10mM of THPTS have a
dramatic bactericidal effect leading to the total absence of colony.
Using 100 mM of THPTS we observed a bactericidal effect of
more than 2log even with higher concentration of serum (50 to
100%). Each point is the mean 6 standard deviation of three
experiments (P,0.005). Control: no THPTS incubation; dark
toxicity: THPTS incubation but no light exposure; illumination:
photoinactivation using indicated THPTS concentrations. Arrows
indicate a complete absence of bacteria.
Found at: doi:10.1371/journal.pone.0011674.s001 (0.03 MB
DOC)
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